Topic
IPO Research
The current environment for IPOs is shaped by a resilient but narrow market rally, primarily driven by technology and software sector gains that set a high performance bar for new entrants. Research indicates a significant pipeline of potential candidates emerging from the massive AI buildout, where hyperscaler capital expenditure is projected to hit $1 trillion annually by 2028. While private equity and venture capital continue to attract interest due to historical outperformance, the rise of liquid vehicles tracking these segments has increased their correlation with public large-cap benchmarks. Institutional sentiment remains focused on quality fundamentals and U.S. large-cap core exposure, suggesting that upcoming offerings will face rigorous scrutiny regarding leverage and valuation metrics. Furthermore, expectations of stable Federal Reserve policy in the near term, followed by potential rate cuts as growth slows, may provide a stabilizing macro backdrop for valuation discovery. Ultimately, the research suggests that while market volatility remains a concern, the strategic shift toward active management and private market diversification is redefining the bridge between private funding and public equity listings.
4275 reports available
All reports
Page 65 of 179
Midday Market Intelligence
Goldman Sachs · Jun 10, 2026
Equity Client Flow Trends
Bank of America · Jun 10, 2026
Australian Morning Focus
ANZ · Jun 10, 2026
NY Open Incrementalism
Citigroup Inc. · Jun 10, 2026
Russell 2k Rescued By Rotation
Goldman Sachs · Jun 10, 2026
A Markets Guide to the World Cup
Citi · Jun 10, 2026
Global Equities Call
Goldman Sachs · Jun 10, 2026
New Zealand Morning Focus
ANZ · Jun 10, 2026
EU Consumer Sector Specialist Commentary
J.P. Morgan · Jun 10, 2026
Flow of Funds Systematic Update
Goldman Sachs · Jun 10, 2026
Vertex Pharmaceuticals Inc. Key Takeaways
Goldman Sachs · Jun 10, 2026
Ardent Health Inc. Key Takeaways
Goldman Sachs · Jun 10, 2026
Taiwan GDP Upgrade On Export Surprise
ANZ · Jun 10, 2026
Gilead Sciences Inc. (GILD): 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
G10 FX Daily Report
JPMorganChase · Jun 10, 2026
New Amsterdam Pharma 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
China Healthcare Hospital Equipment Bidding Update
Goldman Sachs · Jun 10, 2026
EMEA Special Situations Specialist Commentary
J.P. Morgan · Jun 10, 2026
Moderna Inc. Key Takeaways 47th Annual Global Healthcare Conference
Goldman Sachs · Jun 10, 2026
The Point For Europe
Citi · Jun 10, 2026
US Equity Unwind Repeats Friday's Playbook
Citi · Jun 10, 2026
US Strategy Views Supply And Demand
Goldman Sachs · Jun 10, 2026
The Point for Asia Pacific
Citi · Jun 10, 2026
Novo Nordisk Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026